Is biomarker testing covered by insurance or government schemes — here's what's actually paid for

Sometimes, but rarely by default. Aarogyasri and PM-JAY are built around fixed treatment packages, so a standalone biomarker test is often not itemised as a separate reimbursable cost, even when your overall treatment is approved. Private insurance and CGHS or ECHS can cover it, but usually only with a clear prescription and written confirmation first.

This page explains what's typically covered, what typically isn't, and the exact steps that improve your chances of reimbursement — not from theory, but from the pattern most Indian patients run into between diagnosis and starting immunotherapy.

The bigger problem isn't that testing is never covered — it's that most families only find out it wasn't, after they've already paid and the sample has been sent.

This is a general pattern, not a guarantee for your specific policy, hospital or package code — schemes and insurers update their rules, and CION does not decide or process your claim on your behalf.

1. 1

   Get a specific prescription

   Ask your oncologist to name the exact test on your prescription or case sheet — for example, "PD-L1 IHC 22C3", not just "biomarker testing". Vague wording is one of the most common reasons a claim is questioned.

2. 2

   Confirm coverage before the sample is sent

   Call your insurer or scheme desk and get written confirmation — an email or an approval letter — that this specific test is payable, rather than assuming it based on your overall treatment being covered.

3. 3

   Use a recognised or empanelled lab where required

   CGHS, ECHS, Aarogyasri and PM-JAY often reimburse only tests performed at listed or empanelled facilities. Ask before choosing where the sample goes.

4. 4

   Keep every document together

   Prescription, lab invoice, report, and any prior-approval letter — submitted together, these are what a claims desk actually asks for.

Government schemes like Aarogyasri and PM-JAY are designed around the cost of treating the disease, not around individual diagnostic line items — so a biomarker test ordered before treatment begins can fall into a grey zone the package was never built to cover.

Private insurance adds a second layer of friction: a test done as part of an outpatient workup, before any hospital admission, is sometimes treated differently from a test billed during an inpatient stay, depending on your policy's specific wording.

The result is that many families pay for biomarker testing entirely out of pocket, simply because nobody checked coverage before the sample was collected — not because the scheme or the insurer would never have paid.

• A specific prescription — naming the exact test avoids the ambiguity that gets claims sent back for clarification.
• Pre-authorisation over post-payment — wherever a scheme allows written approval in advance, get it before the sample is sent, not after the bill arrives.
• A listed or empanelled lab — confirm the lab is recognised under your specific scheme before choosing where the test is performed.
• One clear paper trail — keep the prescription, invoice, report and any approval letter in one place from day one.

None of this guarantees approval — insurers and schemes make the final call on your specific policy or package.

Biomarker and genomic tests in this workflow are processed at partner diagnostic laboratories, not performed in-house at CION centres. Our oncology team helps decide which test you actually need, explains the report once it's back, and can talk through the coverage questions above with you — the insurance or scheme claim itself is handled between you, the testing laboratory, and your insurer or scheme desk.

• Tumour Mutational Burden (TMB): What a High Score Means — another biomarker that can decide eligibility, explained the same way.
• IHC, NGS and Liquid Biopsy: Which Test Is Which? — why some tests cost a few thousand rupees and others cost far more.
• How Long Do Biomarker Results Take, and Why the Wait? — what to expect between sending the sample and getting a usable report.
• Immunotherapy at CION Cancer Clinics — the full picture of how CION supports patients through testing and treatment.

This page describes typical insurance and scheme practice as of August 2026 and does not replace direct confirmation from your insurer, scheme desk, or hospital billing team. Coverage rules change and vary by policy, package and hospital.

Thousands of families have navigated testing and treatment costs with us

Getting the right test, at the right cost, is part of starting safely. Our team walks this part of the journey with you too.